Designer Exosomes for Targeted Delivery of a Novel Therapeutic Cargo to Enhance Sorafenib-Mediated Ferroptosis in Hepatocellular Carcinoma

Sorafenib is one of the few effective first-line drugs approved for the treatment of advanced hepatocellular carcinoma (HCC). However, the development of drug resistance is common among individuals with HCC. Recent evidence indicated that the anticancer activity of sorafenib mainly relies on the ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaoju, Yu, Qianqian, Zhao, Runze, Guo, Xinyan, Liu, Chenlin, Zhang, Kuo, Zhang, Wangqian, Liu, Jinghan, Yu, Jinzheng, Wang, Shuning, Hao, Qiang, Li, Weina, Zhang, Wei, Li, Meng, Zhang, Yingqi, Zhang, Cun, Gao, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263838/
https://www.ncbi.nlm.nih.gov/pubmed/35814401
http://dx.doi.org/10.3389/fonc.2022.898156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263838/
https://www.ncbi.nlm.nih.gov/pubmed/35814401
http://dx.doi.org/10.3389/fonc.2022.898156

Ejemplares similares